Isolation of human fibroadipogenic progenitors and satellite cells from frozen muscle biopsies.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
09 2021
Historique:
revised: 08 07 2021
received: 07 04 2021
accepted: 12 07 2021
entrez: 18 8 2021
pubmed: 19 8 2021
medline: 10 9 2021
Statut: ppublish

Résumé

Skeletal muscle contains multiple cell types that work together to maintain tissue homeostasis. Among these, satellite cells (SC) and fibroadipogenic progenitors cells (FAPs) are the two main stem cell pools. Studies of these cells using animal models have shown the importance of interactions between these cells in repair of healthy muscle, and degeneration of dystrophic muscle. Due to the unavailability of fresh patient muscle biopsies, similar analysis of interactions between human FAPs and SCs is limited especially among the muscular dystrophy patients. To address this issue here we describe a method that allows the use of frozen human skeletal muscle biopsies to simultaneously isolate and grow SCs and FAPs from healthy or dystrophic patients. We show that while the purified SCs differentiate into mature myotubes, purified FAPs can differentiate into adipocytes or fibroblasts demonstrating their multipotency. We find that these FAPs can be immortalized and the immortalized FAPs (iFAPs) retain their multipotency. These approaches open the door for carrying out personalized analysis of patient FAPs and interactions with the SCs that lead to muscle loss.

Identifiants

pubmed: 34405910
doi: 10.1096/fj.202100588R
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21819

Informations de copyright

© 2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Références

Farup J, Madaro L, Puri PL, et al. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Cell Death Dis. 2015;6:e1830.
Chazaud B. Inflammation and skeletal muscle regeneration: leave it to the macrophages! Trends Immunol. 2020;41:481-492.
Munoz-Canoves P, Serrano AL. Macrophages decide between regeneration and fibrosis in muscle. Trends Endocrinol Metab. 2015;26:449-450.
Heredia J, Mukundan L, Chen F, et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell. 2013;153:376-388.
Uezumi A, Fukada S-I, Yamamoto N, et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol. 2010;12:143-152.
Latroche C, Weiss-Gayet M, Gitiaux C, et al. Cell sorting of various cell types from mouse and human skeletal muscle. Methods. 2018;134-135:50-55.
Perdiguero E, Moiseeva V, Munoz-Canoves P. Simultaneous isolation of stem and niche cells of skeletal muscle: applicability for aging studies. Methods Mol Biol. 2019;2045:13-23.
Tucciarone L, Etxaniz U, Sandona M, et al. Advanced methods to study the cross talk between fibro-adipogenic progenitors and muscle stem cells. Methods Mol Biol. 2018;1687:231-256.
Uezumi A, Kasai T, Tsuchida K. Identification, isolation, and characterization of mesenchymal progenitors in mouse and human skeletal muscle. Methods Mol Biol. 2016;1460:241-253.
Uezumi A, Fukada S, Yamamoto N, et al. Identification and characterization of PDGFRalpha+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis. 2014;5:e1186.
Carter LS, Askanas V. Vital-freezing of human muscle cultures for storage and reculture. Muscle Nerve. 1981;4:367-369.
Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676-682.
Mamchaoui K, Trollet C, Bigot A, et al. Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet Muscle. 2011;1:34.
Halfon S, Abramov N, Grinblat B, et al. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011;20:53-66.
Consalvi S, Saccone V, Mozzetta C. Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy. Epigenomics. 2014;6:547-560.
Hogarth MW, Defour A, Lazarski C, et al. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nat Commun. 2019;10:2430.
Ito T, Ogawa R, Uezumi A, et al. Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors. Neuromuscul Disord. 2013;23:349-356.
Kasai T, Nakatani M, Ishiguro N, et al. Promethazine hydrochloride inhibits ectopic fat cell formation in skeletal muscle. Am J Pathol. 2017;187:2627-2634.
Mazala DA, Novak JS, Hogarth MW, et al. TGF-beta-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model. JCI Insight. 2020;5:e135703.
Mozzetta C, Consalvi S, Saccone V, et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med. 2013;5:626-639.
Sandonà M, Consalvi S, Tucciarone L, et al. HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells. EMBO Rep. 2020;21:e50863.
Massenet J, Gitiaux C, Magnan M, et al. Derivation and characterization of immortalized human muscle satellite cell clones from muscular dystrophy patients and healthy individuals. Cells. 2020;9:1780.
Auré K, Mamchaoui K, Frachon P, et al. Impact on oxidative phosphorylation of immortalization with the telomerase gene. Neuromuscul Disord. 2007;17:368-375.
Thorley M, Duguez S, Mazza EMC, et al. Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines. Skelet Muscle. 2016;6:43.
Körner A, Wabitsch M, Seidel B, et al. Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun. 2005;337:540-550.
Sibov TT, Severino P, Marti LC, et al. Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation. Cytotechnology. 2012;64:511-521.
Giordani L, He GJ, Negroni E, et al. High-dimensional single-cell cartography reveals novel skeletal muscle-resident cell populations. Mol Cell. 2019;74(609-621):e6.
Oprescu SN, Yue F, Qiu J, et al. Temporal dynamics and heterogeneity of cell populations during skeletal muscle regeneration. iScience, 2020;23:100993.
Petrilli LL, Spada F, Palma A, et al. High-dimensional single-cell quantitative profiling of skeletal muscle cell population dynamics during regeneration. Cells. 2020;9:1723.
De Micheli AJ, Spector JA, Elemento O, et al. A reference single-cell transcriptomic atlas of human skeletal muscle tissue reveals bifurcated muscle stem cell populations. Skelet Muscle. 2020;10:19.
Rubenstein AB, Smith GR, Raue U, et al. Single-cell transcriptional profiles in human skeletal muscle. Sci Rep. 2020;10:229.

Auteurs

Xavier Suárez-Calvet (X)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Centro de Investigaciones Biomédicas en Red en Enfermedades Raras (CIBERER), Madrid, Spain.

Esther Fernández-Simón (E)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
John Walton Muscular Dystrophy Research Center, University of Newcastle, Newcastle upon Tyne, UK.

Patricia Piñol-Jurado (P)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
John Walton Muscular Dystrophy Research Center, University of Newcastle, Newcastle upon Tyne, UK.

Jorge Alonso-Pérez (J)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.

Ana Carrasco-Rozas (A)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.

Cinta Lleixà (C)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.

Susana López-Fernández (S)

Plastic Surgery Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

Gemma Pons (G)

Plastic Surgery Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

Laura Soria (L)

Orthopaedics and Traumatology Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

Anne Bigot (A)

Center for Research in Myology, Sorbonne Université, Inserm, Institut de Myologie, U974, Paris, France.

Vincent Mouly (V)

Center for Research in Myology, Sorbonne Université, Inserm, Institut de Myologie, U974, Paris, France.

Isabel Illa (I)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Centro de Investigaciones Biomédicas en Red en Enfermedades Raras (CIBERER), Madrid, Spain.

Eduard Gallardo (E)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Centro de Investigaciones Biomédicas en Red en Enfermedades Raras (CIBERER), Madrid, Spain.

Jyoti K Jaiswal (JK)

Department of Genomics and Precision Medicine, George Washington University School of Medicine and Health Sciences, and Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.

Jordi Díaz-Manera (J)

Neuromuscular Diseases Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Centro de Investigaciones Biomédicas en Red en Enfermedades Raras (CIBERER), Madrid, Spain.
John Walton Muscular Dystrophy Research Center, University of Newcastle, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH